Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Regorafenib
Trade Name Stivarga
Synonyms BAY 73-4506
Drug Descriptions

Stivarga (regorafenib) is an inhibitor of several kinases including VEGFR, RET, KIT, PDGFR and RAF, thereby inhibiting tumor angiogenesis and tumor cell proliferation (PMID: 24756792). Stivarga (regorafenib) is FDA approved for colorectal cancer, hepatocellular carcinoma, and GIST (FDA.gov).

DrugClasses BRAF Inhibitor 25 CRAF Inhibitor 12 KIT Inhibitor 57 PDGFR Inhibitor (Pan) 30 RET Inhibitor 53 VEGFR Inhibitor (Pan) 36 VEGFR2 Inhibitor 37
CAS Registry Number 755037-03-7
NCIT ID C78204

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Aldoxorubicin + Avelumab + Capecitabine + Cetuximab + Cyclophosphamide + ETBX-011 + ETBX-021 + ETBX-051 + ETBX-061 + Fluorouracil + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Nogapendekin alfa inbakicept + Oxaliplatin + Regorafenib + Trastuzumab Aldoxorubicin Avelumab Capecitabine Cetuximab Cyclophosphamide ETBX-011 ETBX-021 ETBX-051 ETBX-061 Fluorouracil GI-4000 GI-6207 GI-6301 Leucovorin Nab-paclitaxel Nogapendekin alfa inbakicept Oxaliplatin Regorafenib Trastuzumab haNK cells 0 1
Ascrinvacumab + Regorafenib Ascrinvacumab Regorafenib 0 1
Aspirin + Bevacizumab + Capecitabine + Cyclophosphamide + Fluorouracil + Irinotecan + Leucovorin + Regorafenib Aspirin Bevacizumab Capecitabine Cyclophosphamide Fluorouracil Irinotecan Leucovorin Regorafenib 0 1
Aspirin + Bevacizumab + Capecitabine + Cyclophosphamide + Fluorouracil + Leucovorin + Oxaliplatin + Regorafenib Aspirin Bevacizumab Capecitabine Cyclophosphamide Fluorouracil Leucovorin Oxaliplatin Regorafenib 0 1
Aspirin + Capecitabine + Cyclophosphamide + Regorafenib Aspirin Capecitabine Cyclophosphamide Regorafenib 0 2
Avelumab + Regorafenib Avelumab Regorafenib 0 1
Azacitidine + Regorafenib Azacitidine Regorafenib 0 1
Azacitidine + Regorafenib + Venetoclax Azacitidine Regorafenib Venetoclax 0 1
Balstilimab + Botensilimab + Regorafenib Balstilimab Botensilimab Regorafenib 0 2
Capecitabine + Regorafenib Capecitabine Regorafenib 0 1
Capecitabine + Regorafenib + Ruxolitinib Capecitabine Regorafenib Ruxolitinib 0 1
Cetuximab + Regorafenib Cetuximab Regorafenib 1 2
Chloroquine + Regorafenib Chloroquine Regorafenib 0 0
Clobetasol + Regorafenib Clobetasol Regorafenib 0 1
Crizotinib + Regorafenib Crizotinib Regorafenib 0 0
Crizotinib + Regorafenib + Tislelizumab Crizotinib Regorafenib Tislelizumab 0 0
CVX-060 + Regorafenib CVX-060 Regorafenib 0 0
Cyclophosphamide + Doxorubicin + Etoposide + Ifosfamide + Regorafenib + Vincristine Sulfate Cyclophosphamide Doxorubicin Etoposide Ifosfamide Regorafenib Vincristine Sulfate 0 1
Cyclophosphamide + Etoposide + Ifosfamide + Regorafenib + Vincristine Sulfate Cyclophosphamide Etoposide Ifosfamide Regorafenib Vincristine Sulfate 0 1
Dabrafenib + Regorafenib + Trametinib Dabrafenib Regorafenib Trametinib 3 0
DHA + Regorafenib DHA Regorafenib 0 0
Durvalumab + Regorafenib Durvalumab Regorafenib 0 3
Entinostat + Hydroxychloroquine + Regorafenib Entinostat Hydroxychloroquine Regorafenib 0 1
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + Regorafenib Fluorouracil Leucovorin Nivolumab Oxaliplatin Regorafenib 0 1
Fluorouracil + Leucovorin + Oxaliplatin + Regorafenib Fluorouracil Leucovorin Oxaliplatin Regorafenib 0 1
Fluorouracil + Leucovorin + Regorafenib Fluorouracil Leucovorin Regorafenib 0 1
Fulvestrant + Regorafenib Fulvestrant Regorafenib 0 1
Gemcitabine + Regorafenib Gemcitabine Regorafenib 0 1
Ipilimumab + Nivolumab + Regorafenib Ipilimumab Nivolumab Regorafenib 0 1
Irinotecan + Regorafenib Irinotecan Regorafenib 0 1
Irinotecan + Regorafenib + Vincristine Sulfate Irinotecan Regorafenib Vincristine Sulfate 0 1
Methotrexate + Regorafenib Methotrexate Regorafenib 0 1
MK2206 + Regorafenib + Sorafenib MK2206 Regorafenib Sorafenib 0 0
Napabucasin + Regorafenib Napabucasin Regorafenib 0 1
NEO212 + Regorafenib NEO212 Regorafenib 0 1
Nivolumab + Regorafenib Nivolumab Regorafenib 0 7
Panitumumab + Regorafenib Panitumumab Regorafenib 0 1
Pembrolizumab + Regorafenib Pembrolizumab Regorafenib 0 5
Perindopril + Regorafenib Perindopril Regorafenib 0 1
Pimasertib + Regorafenib Pimasertib Regorafenib 3 0
Refametinib + Regorafenib Refametinib Regorafenib 0 1
Regorafenib Regorafenib 75 74
Regorafenib + SBI-0206965 Regorafenib SBI-0206965 0 0
Regorafenib + Sorafenib Regorafenib Sorafenib 0 0
Regorafenib + Spartalizumab Regorafenib Spartalizumab 0 1
Regorafenib + Sugemalimab Regorafenib Sugemalimab 0 1
Regorafenib + Sunitinib Regorafenib Sunitinib 0 0
Regorafenib + Temozolomide Regorafenib Temozolomide 0 1
Regorafenib + Trametinib Regorafenib Trametinib 2 0
Regorafenib + Trifluridine-tipiracil hydrochloride Regorafenib Trifluridine-tipiracil hydrochloride 0 5
Regorafenib + XmAb20717 Regorafenib XmAb20717 0 1


Additional content available in CKB BOOST